10.20.23
Nutriventia Limited, a dietary supplement ingredient supplier, has established incorporation in the U.S., as the company plans to expand into the U.S. market. The company also added two people to executive leadership roles, announced Rajat Mittal Shah, co-founder and executive director.
Jennifer Clancy has been appointed as global marketing director, and Neha Thomas has been named sales director, USA.
Clancy previously was a customer experience marketing leader at IFF. “In the realm of brand brilliance, Jennifer brings over 20 years of experience to our team,” said Shah. “She stands as a seasoned marketing executive, meticulously crafting influential brands that resonate across the global marketplace.”
Neha Thomas brings 15 years of experience to Nutriventia, and has a background in chemistry which she will use to present the portfolio of the company’s ingredients to the U.S. market.
“Nutriventia is poised to continue expanding our business well beyond our home base of India, particularly in the U.S.,” Shah said. “The addition of high-level experienced marketing and sales leads, as well as formalizing our corporate status in the U.S., means that we have a solid launch pad for the exciting new developments in science and product innovation going forward.”
“Focusing on ‘low dose, high impact’ as a benchmark for our ingredients, we anticipate high trial and repeat purchase rates of products containing them by consumers attracted to the sustained-release attribute,” said Anand Godbole, vice president of business development. “Today’s proactive natural health consumer appreciates products that are easy to take – one and done – allowing them to reap the benefit while moving at their own pace.”
Shah noted that Nutriventia has been focusing on R&D to better expand into global markets. It has achieved patents in the U.S., the UK, and India for its flagship turmeric ingredient TurmXTRA.
“These patents have been a priority in the innovation pipeline at Nutriventia and apply to the curcuminoid formulations exhibiting rapid dissolution and optimizing bioavailability from a low 250 mg once daily dose,” she said. “TurmXTRA is also Clean Label Project certified, as it uses excipients obtained from natural sources and is derived from a solvent free manufacturing process.”
Other ingredients in Nutriventia’s profile include sustained-release caffeine CaffXtend, sustained-release melatonin Melotime, optimized vitamin C granule ingredient C-Fence, and ashwagandha extract Prolanza.
“We anticipate more human clinical trials on our ingredients, as well as the introduction of new science-backed ingredients in the near future,” Shah said.
Jennifer Clancy has been appointed as global marketing director, and Neha Thomas has been named sales director, USA.
Clancy previously was a customer experience marketing leader at IFF. “In the realm of brand brilliance, Jennifer brings over 20 years of experience to our team,” said Shah. “She stands as a seasoned marketing executive, meticulously crafting influential brands that resonate across the global marketplace.”
Neha Thomas brings 15 years of experience to Nutriventia, and has a background in chemistry which she will use to present the portfolio of the company’s ingredients to the U.S. market.
“Nutriventia is poised to continue expanding our business well beyond our home base of India, particularly in the U.S.,” Shah said. “The addition of high-level experienced marketing and sales leads, as well as formalizing our corporate status in the U.S., means that we have a solid launch pad for the exciting new developments in science and product innovation going forward.”
“Focusing on ‘low dose, high impact’ as a benchmark for our ingredients, we anticipate high trial and repeat purchase rates of products containing them by consumers attracted to the sustained-release attribute,” said Anand Godbole, vice president of business development. “Today’s proactive natural health consumer appreciates products that are easy to take – one and done – allowing them to reap the benefit while moving at their own pace.”
Shah noted that Nutriventia has been focusing on R&D to better expand into global markets. It has achieved patents in the U.S., the UK, and India for its flagship turmeric ingredient TurmXTRA.
“These patents have been a priority in the innovation pipeline at Nutriventia and apply to the curcuminoid formulations exhibiting rapid dissolution and optimizing bioavailability from a low 250 mg once daily dose,” she said. “TurmXTRA is also Clean Label Project certified, as it uses excipients obtained from natural sources and is derived from a solvent free manufacturing process.”
Other ingredients in Nutriventia’s profile include sustained-release caffeine CaffXtend, sustained-release melatonin Melotime, optimized vitamin C granule ingredient C-Fence, and ashwagandha extract Prolanza.
“We anticipate more human clinical trials on our ingredients, as well as the introduction of new science-backed ingredients in the near future,” Shah said.
